Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Interest Expenses (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Interest Expenses for 17 consecutive years, with $23.7 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 24.7% to $23.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86.3 million through Dec 2025, up 22.12% year-over-year, with the annual reading at $86.3 million for FY2025, 22.12% up from the prior year.
  • Interest Expenses hit $23.7 million in Q4 2025 for Integra Lifesciences Holdings, up from $22.7 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $23.7 million in Q4 2025 to a low of $11.7 million in Q1 2022.
  • Historically, Interest Expenses has averaged $15.4 million across 5 years, with a median of $13.1 million in 2021.
  • Biggest five-year swings in Interest Expenses: tumbled 41.37% in 2021 and later soared 49.64% in 2024.
  • Year by year, Interest Expenses stood at $12.1 million in 2021, then rose by 6.34% to $12.9 million in 2022, then grew by 6.65% to $13.8 million in 2023, then skyrocketed by 38.06% to $19.0 million in 2024, then grew by 24.7% to $23.7 million in 2025.
  • Business Quant data shows Interest Expenses for IART at $23.7 million in Q4 2025, $22.7 million in Q3 2025, and $21.0 million in Q2 2025.